FDA Investigator Nadine Nanko Johnson
Nadine Nanko Johnson has inspections in 1 countries as of 03 Mar 2023. Nadine Nanko Johnson has collaborated with a combined 735 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
03 Mar 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Ashley A Mutawakkil,
Bonnie E Pierson,
Brenda C Hamilton,
Brett R Havranek,
Chilton L Ng,
Dana D Carter, SR DDS,
Daniel R Hurt,
Dewayne E Whitlock,
Eric C Fox,
Farhana Khan,
Gwyn G Dickinson,
James D Planchon,
James P Mcreavey,
Jessica E Hensley,
Jonathan R Campos,
Judith Hillegas,
Julie N Vosilus,
Kara L Roden,
Kellia N Hicks,
Kelly D Sheppard,
LCDR Matthew J Morrison,
Linhart,
Linwood R Daughtry,
Lisa L Gilliam,
Lori A Gioia,
Mark E Parmon,
Matthew A Walburger,
Matthew P Barnard,
Matthew P Bernard,
Matthew R Sleeter,
Michael S Smoker,
Michele L Obert,
Minerva Rogers,
Nadine J Nanko,
Patrick L Wisor,
Rita K Kabaso,
Robin K Hatfield,
Robin K Reel,
State Agency,
Tara L Greene,
Tara L King,
Veronica Fuentes, MS,
Wayne D Mcgrath
Nadine Nanko Johnson's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2001 | FDA 483 | Mesa Laboratories Inc - Form 483, 2001-07-20 |
April, 2000 | FDA 483 | Custom Industrial Analysis Laboratories - Form 483, 2000-04-18 |
May, 2001 | FDA 483 | Remel, Inc - Form 483, 2001-05-30 |
May, 2000 | FDA 483 | Cramer Products Inc - Form 483, 2000-05-17 |
May, 2001 | EIR | Remel, Inc - EIR, 2001-05-30 |
July, 2001 | EIR | Mesa Laboratories Inc - EIR, 2001-07-20 |
July, 2001 | FDA 483 Response | Mesa Laboratories Inc - Form 483R, 2001-07-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more